Description: Nebivolol is a racemate composed of d-Nebivolol & l-Nebivolol with the stereochemical designations of [SRRR]-Nebivolol and [RSSS]¬Nebivolol, respectively.
Indication:
Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.